Ron Eastman
InvestorSenior Advisor at Essex Woodlands Healthcare Partners
About
Ron Eastman joined Essex Woodlands (EW) in 2006 and was a Managing Director across multiple funds before becoming a Senior Advisor in 2021. He has decades of experience building healthcare businesses, beginning at American Cyanamid Company and later serving as CEO of Geron and leading Rinat Neuroscience, a Genentech spinout acquired by Pfizer in 2006. He holds a B.A. from Williams College and an M.B.A. from Columbia University.
Invests in
BiotechHealthtech
Investments
Led
CoriumElusys TherapeuticsEyePoint PharmaceuticalsProteinSimple
Board seats
Suneva
Per the firm's website.
Colleagues at Essex Woodlands Healthcare Partners
AndY Thomson
Operating Partner at Essex Woodlands Healthcare Partners
Bill Hawkins
Senior Advisor at Essex Woodlands Healthcare Partners
Bob White
Operating Partner at Essex Woodlands Healthcare Partners
Brooks Andrews
Managing Director at Essex Woodlands Healthcare Partners
Bryan Morton
Operating Partner at Essex Woodlands Healthcare Partners
Evis Hursever
CEO at Essex Woodlands Healthcare Partners
Fredrik Thorell
Senior Principal at Essex Woodlands Healthcare Partners
Greg Hill
Chief Financial Officer / Chief Compliance Officer at Essex Woodlands Healthcare Partners